Cell Therapeutics (CTIC) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Cell Therapeutics (CTIC)

An SI Board Since August 1997

Posts	SubjectMarks	Bans	Symbol
946	45	0	CTIC

Emcee: Regis McConnell	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
421	Not only was the price increase of the March 10 call significant. Volume: 16,0	Sam Citron	-	2/16/2005
420	No need to worry my little head - some one on the Yahoo board explained that it	tom pope	-	2/16/2005
419	Interesting - suggests the results might be out before the March expiration and	Biomaven	-	2/16/2005
418	This is weird - the stock is down but the Mar 10 calls are up sharply.	tom pope	-	2/16/2005
417	The much larger Phase II's at a lower dose didn't report similar issues,	Biomaven	-	2/16/2005
416	I don't think the markets are aware of these results yet. The abstract just	Icebrg	-	2/16/2005
415	I was about to ask Erik the same question. It sounds pretty dire to me, unless i	tom pope	-	2/16/2005
414	Do you think the market has discounted these results?	D.Lu	-	2/16/2005
413	Phase I study of the novel taxane CT-2103 in patients with advanced solid tumors	Icebrg	-	2/16/2005
412	XYOTAX Patent Allowance Provides Exclusivity in Europe Until 2017 Tuesday Februa	scaram(o)uche	-	2/8/2005
411	<i>I think those specific but undisclosed performance goals are pretty com	Doc Bones	-	2/4/2005
410	It depends upon whether I'm the shareholder being robbed or the manager doin	Ian@SI	-	2/4/2005
409	whats the matter? you dont believe in retroactive management incentives?	Madharry	-	2/3/2005
408	I think those specific but undisclosed performance goals are pretty commonplace.	Madharry	-	2/3/2005
407	Unless the thieving pricks dilute all of the shareholders wealth until it ends u	Ian@SI	-	2/2/2005
406	The real sleaze here is of course not the 50 % which vest upon FDA's approva	Icebrg	-	2/2/2005
405	Well, they are of course not trading themselves. They just happen to be fortunat	Icebrg	-	2/2/2005
404	not to belabour this point, but if i understand you correctly, aren't you re	former_pgs	-	2/2/2005
403	>>Do you mean investigators with long experience in paclitaxel type treatm	Icebrg	-	2/2/2005
402	Erik--and the market seems to agree with your assessment. (I was putting my ton	quidditch	-	2/2/2005
401	>>one must question whether this management's "belief" is cr	Icebrg	-	2/2/2005
400	Erik, "To tie the vesting to an approval under such circumstances does of c	quidditch	-	2/2/2005
399	At least it is a very positive signal. Especially as they cannot do much more	Icebrg	-	2/2/2005
398	so i guess their greed is our gain? :-)	former_pgs	-	2/2/2005
397	>>As you said, the timing is completely irresponsible.>> Yes, it is	Icebrg	-	2/2/2005

Go to reply# or date (mm/dd/yy):